The EuroHYP-1 trial is a pan-European, open, randomised, phase III clinical trial which will assess the benefit of therapeutic cooling in adult patients with acute ischaemic stroke. In addition to efficacy and safety, the economic impact of therapeutic hypothermia will be also evaluated.

The EuroHYP consortium brings together leading European experts in statistical design and analysis, therapeutic hypothermia, imaging, health economics, ultrasound, biomarkers, and trial execution (implementation and monitoring) as well as European patient and family advocacy groups and Small and Medium-size Enterprises.

On the following pages you will find more information about the projectproject partners and patient enrolment.

European Stroke Organisation Conference 2015 in Glasgow

EuroHYP-1 will be present at the European Stroke Organisation Conference in Glasgow from 17 – 19 April 2015

Come and visit us at stand 25 in the ESOC Exhibition area!

More information on the conference:

The EuroHYP-1 Consortium

The EuroHYP-1 Consortium at the Kick-off Meeting in Munich
The EuroHYP-1 Consortium at the Kick-off Meeting in Munich